Activity Code
R01 Research Project Grant
Funding Opportunity Announcement (FOA) Number
PA-18-859
The purpose of this Funding Opportunity Announcement is to support research activities that will advance NIAID’s mission to develop a universal influenza vaccine providing durable protection against multiple influenza strains, including efforts to: 1) improve understanding of transmission, natural history and pathogenesis of influenza virus infection; 2) characterize influenza immunity and correlates of immune protection; and 3) support rational design of universal influenza vaccines. This FOA uses the R01 grant mechanism, while the companion FOA,
PA-18-858, uses the R21 mechanism. Applicants with preliminary data and/or planning longer-term studies may wish to apply using the R01 mechanism. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism.
Eligibility
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply
Award
Application budgets are not limited but need to reflect the actual needs of the proposed project.
The maximum project period is 5 years
Key Dates
Open Date (Earliest Submission Date)
September 05, 2018
